(Q28180159)

7

object named as

Edward H Oldfield

0 references

Steven Libutti

5

object named as

Steven K Libutti

0 references

Russell R. Lonser

1

object named as

Russell R Lonser

0 references

author name string

Gladys M Glenn

2

0 references

McClellan Walther

3

0 references

W Marston Linehan

Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer

6

0 references

language of work or name

English

0 references

publication date

14 June 2003

0 references

published in

The Lancet

0 references

volume

361

0 references

issue

9374

0 references

page(s)

2059-67

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Von Hippel-Lindau disease: clinical and molecular perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

von Hippel-Lindau Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Molecular basis of the VHL hereditary cancer syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

A genetic register for von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

von Hippel-Lindau disease affecting 43 members of a single kindred

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Pancreatic involvement in von Hippel–Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Von Hippel-Lindau Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Von Hippel-Lindau disease: a genetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Central nervous system lesions in von Hippel-Lindau syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

von Hippel-Lindau disease: genetic, clinical, and imaging features

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Identification of the von Hippel-Lindau disease tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Genetics of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Mutation of the Von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Mutations of the VHL tumour suppressor gene in renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: an in vivo study on 29 tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

The von Hippel-Lindau tumour suppressor protein: new perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Inhibition of Transcription Elongation by the VHL Tumor Suppressor Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Expression of growth factors and growth factor receptors in capillary hemangioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Two HIFs may be better than one.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

The von Hippel-Lindau Tumor Suppressor Gene Product Interacts with Sp1 To Repress Vascular Endothelial Growth Factor Promoter Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

LINDAU'S DISEASE. REVIEW OF THE LITERATURE AND STUDY OF A LARGE KINDRED.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Central nervous system involvement in Von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Radiosurgical treatment of a hemangioblastoma: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Stereotactic multiple are radiotherapy. IV--Haemangioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Gamma knife radiosurgery in 11 hemangioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Stereotaxic radiosurgical ablation: an alternative treatment for recurrent and multifocal hemangioblastomas. A report of four cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Radiosurgery for hemangioblastoma: Results of a multiinstitutional experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Treatment of retinal capillary hemangioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Percutaneous radio frequency ablation of small renal tumors: initial results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Partial adrenalectomy in patients with multiple adrenal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Pancreatic lesions in the von Hippel-Lindau syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Papillary cystadenoma of epididymis: component of von Hippel-Lindau syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Papillary cystadenoma of the epididymis. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Papillary Cystadenoma of the Epididymis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Epididymal cystadenomas in von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Papillary cystadenoma of the broad ligament in a patient with von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

Papillary cystadenoma of the mesosalpinx in von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913643-4

7 January 2021

10.1016/S0140-6736(03)13643-4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

12814730

1 reference

Consolidated OpenCitations Corpus – April 2017